Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer.
Meng J, Peng J, Feng J, Maurer J, Li X, Li Y, Yao S, Chu R, Pan X, Li J, Zhang T, Liu L, Zhang Q, Yuan Z, Bu H, Song K, Kong B.
Meng J, et al. Among authors: zhang q, zhang t.
J Transl Med. 2021 Oct 7;19(1):415. doi: 10.1186/s12967-021-03073-0.
J Transl Med. 2021.
PMID: 34620163
Free PMC article.